Skip to main content
Download PDF

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

Journal of Hematology & Oncology volume 9, Article number: 133 (2016) Cite this article

The Original Article was published on 20 October 2015

Erratum

The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section.

The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadvertent omission from the original publication.

Reference

  1. Laszlo GS, et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. J Hematol Oncol. 2015;8:115. doi:10.1186/s13045-015-0215-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D2-190, Seattle, WA, 98109-1024, USA

    George S. Laszlo, Chelsea J. Gudgeon, Kimberly H. Harrington, Rhonda E. Ries, Soheil Meshinchi & Roland B. Walter

  2. Department of Biostatistics, University of Southern California, Los Angeles, CA, USA

    Todd A. Alonzo

  3. Children’s Oncology Group, Monrovia, CA, USA

    Todd A. Alonzo, Robert B. Gerbing, Yi-Cheng Wang, Susana C. Raimondi, Betsy A. Hirsch, Alan S. Gamis & Soheil Meshinchi

  4. Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY, USA

    Alex Kentsis

  5. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Alex Kentsis

  6. Weill Medical College of Cornell University, New York, NY, USA

    Alex Kentsis

  7. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA

    Susana C. Raimondi

  8. Department of Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN, USA

    Betsy A. Hirsch

  9. Division of Hematology-Oncology, Children’s Mercy Hospitals and Clinics, Kansas City, MO, USA

    Alan S. Gamis

  10. Department of Pediatrics, University of Washington, Seattle, WA, USA

    Soheil Meshinchi

  11. Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA

    Roland B. Walter

  12. Department of Epidemiology, University of Washington, Seattle, WA, USA

    Roland B. Walter

Authors
  1. George S. Laszlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd A. Alonzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chelsea J. Gudgeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kimberly H. Harrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alex Kentsis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert B. Gerbing
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi-Cheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rhonda E. Ries
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Susana C. Raimondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Betsy A. Hirsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Alan S. Gamis
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Soheil Meshinchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Roland B. Walter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roland B. Walter.

Additional information

The online version of the original article can be found under doi:10.1186/s13045-015-0215-4.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laszlo, G.S., Alonzo, T.A., Gudgeon, C.J. et al. Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. J Hematol Oncol 9, 133 (2016). https://doi.org/10.1186/s13045-016-0364-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13045-016-0364-0

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us